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ORIGINAL ARTICLEEvaluation of the Relationships Between Computed
Tomography Features, Pathological Findings, and Prognostic
Risk Assessment in Gastrointestinal Stromal Tumors
Elsa Iannicelli, MD,* Francesco Carbonetti, MD,* Giulia Francesca Federici, MD,* Isabella Martini, MD,*
Salvatore Caterino, MD,† Emanuela Pilozzi, MD,‡ Francesco Panzuto, MD,§ Chiara Briani, MD,*
and Vincenzo David, MD*Objectives: The aim of this study was to correlate computed tomography
(CT) findings with pathology in gastrointestinal stromal tumors (GISTs).
Methods: A retrospective evaluation of CT images of 44 patients with
GISTs was performed. Computed tomography findings analyzed were
location, size, margins, degree and pattern of contrast enhancement, angio-
genesis, necrosis, signs of invasion, peritoneal effusion, peritoneal im-
plants, surface ulceration, and calcifications.
Associations between CT features and mitotic rate, Miettinen classes of
risk, lesions size, and among CT features were investigated. χ2 Test and
Fisher test were performed.
Results: Mitotic rate was associated with margins (P = 0.016) and with
adjacent organ invasion (P = 0.043). Pattern of contrast enhancement
(P = 0.002), angiogenesis (P = 0.006), necrosis (P = 0.006), invasion of
adjacent organs (P = 0.011), and margins (P = 0.006) were associated with
classes of risk. Several associations (P < 0.05) between lesion size and CT
features and among all the investigated CT features were found.
Conclusions: Computed tomography features could reflect GIST biol-
ogy being associated with the mitotic rate and with classes of risk.
Key Words: digestive system neoplasm, gastrointestinal stromal tumors,
multidetector computed tomography, risk assessment, mitotic index
(J Comput Assist Tomogr 2017;41: 271–278)
G astrointestinal stromal tumors (GISTs) are rare tumors butthe most common mesenchymal neoplasms of the gastroin-
testinal tract (GI).1,2
The term GIST was created to indicate a distinctive sub-
group of gastrointestinal mesenchymal neoplasms with fusoid
and epitheliod cells or rarely with pleomorphic cells of the GI;
they are believed to originate from interstitial cells of Cajal or their
stem cell-like precursors, and they usually express mutations of
tyrosine kinase protein receptor (KIT) or platelet-derived growth
factor receptor.2,3
The diagnosis of GIST is histological and implemented by
the immunohistochemical marker CD117 (or C-KIT), which is
positive in 95% of cases, whereas the other 5% of GISTs are pos-
itive for platelet-derived growth factor.4 These tumors have a large
spectrum of biological behavior and are different from other solid
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cently reviewed, which takes into account location, size, andmitotic
index of the tumor and stratifies the risk into 5 classes4,5 (Fig. 1).
In this kind of tumor, the biological features play an impor-
tant role for prognosis and evolution; imaging technique such as
contrast-enhanced computed tomography (CECT) is a fundamen-
tal tool for detecting the lesion and staging and for the evaluation
of the treatment response.6–11 Concerning the prognosis, CT can
evaluate the tumor location and size.
The aim of our study was to investigate for any relations be-
tween the morphological GIST CT features and mitotic index,
classes of risk, and lesion size and among all the evaluated CT pa-
rameters, to find whether any CT finding could give a first step
orientation, before the pathological examination, of the biological
behavior of the lesion.
Previous studies, where relations between CT features and
pathological datawere investigated, have been published, but none
of them performed a comprehensive evaluation of the relations be-
tween CT features, mitotic index, classes of risk, and tumor size,
as we propose in our article.10,12–15
MATERIALS AND METHODS
Study Population
Our local research ethics committee approved this study, and
all patients provided written informed consent including informa-
tion about the radiation exposure from the CT examinations.
This retrospective study was conducted reviewing the patho-
logic database of our hospital from January 2010 to November
2015 to select recorded cases with diagnosis of GIST. Seventy-
nine patients were found.
Inclusion criteria for the study were the following: (1) patho-
logically confirmed diagnosis of GIST, (2) availability of a pre-
operative CECT, and (3) histological analysis of the surgical
specimen reporting the lesion size, site of origin, and the mitotic
index. Thirty-five patients were excluded from the analysis be-
cause CECT scan was not available in 30 patients and only biopsy
was carried out in 5 patients. The final number of patients who
matched the inclusion criteria and enrolled the study was 44 (26
men and 18 women; median age, 59 years; range, 30–88 years).
Pathological Examination
Histological diagnosis was based on microscopic morphol-
ogy and immunophenotype. Immunohistochemistry was performed
on freshly cut 3-μm-thick, paraffin-embedded tissue sections using
antibodies against C-KIT/CD117 (Dako A4502, polyclonal rabbit
antihuman), according to manufacturer instructions. All investi-
gated cases showed cytoplasmic/membranous positivity. Mitotic
count was performed on 50 high power fields (HPFs) and expressed
as number of mitoses per 50 HPFs. Neoplasm size was measured
on formalin-fixed sample and was expressed in centimeters.www.jcat.org 271
Health, Inc. All rights reserved.
FIGURE 1. Figure shows the GISTs' risk for progression based on tumor site, size, and mitotic rate according to Miettinen classification.
Iannicelli et al J Comput Assist Tomogr • Volume 41, Number 2, March/April 2017On the basis of mitotic count, neoplasm size, and site, all the
patients were classified in 5 classes of risks (from none to high
risk) and in an “insufficient data” group according to the Miettinen
classification (Fig. 1).4,5
CT Protocol
Computed tomography scans were performed with multide-
tector CTequipment, GE Light Speed 16. The following technical
parameters were used: 120 kV; 120 to 180 mA; gantry rotation
time, 0.5 seconds; beam collimation, 16  1.25 mm; beam pitch,
1; reconstruction thickness, 2.5 mm. The examinations were per-
formed before and after intravenous administration of 120 to
150 mL of iodinated contrast medium with a rate speed of 3 to
3.5 mL/s. Arterial phase images were acquired 30 to 35 seconds
after the injection, and portal venous phase was obtained with a
delay of 70 to 80 seconds. Multiplanar reconstructions on coro-
nal and sagittal planes and maximum intensity projection (MIP)
were performed.
Image Analysis
The original and reconstructed CT images were reviewed on
a picture archiving and communication system (PACS system,
GE) by 2 radiologists in consensus reading, each with more than
10 years of experience in interpreting abdominal CT images,
who recorded the following features: primary tumor location, le-
sion size, margins, growth pattern, intralesional necrosis, ulcera-
tion of the surface, degree and pattern of contrast enhancement,
angiogenesis, invasion of adjacent organs, peritoneal implants,
intralesional calcifications, and peritoneal effusion.
Lymphadenopathies were not evaluated because our study
was not focused on the CT capability to detect metastatic lymph
nodes. All the CT features were evaluated both on unenhanced
and enhanced CT scans; the degree of contrast enhancement
was analyzed and compared on unenhanced and portal phase im-
ages. Location was divided as follows: esophagus, stomach, duo-
denum, jejunum, ileum, colon, and mesentery. Tumor size, based
on the maximal diameter on the CTaxial plane, was classified into
4 classes according to the Miettinen classification: (1) less than or
equal to 2 cm, (2) greater than 2 cm but less than or equal to 5 cm,
(3) greater than 5 cm but less than or equal to 10 cm, and
(4) greater than 10 cm. The margins of the lesions were defined
as regular and irregular: the first one when the edge of the lesion
appeared smooth, clear, and crisp and the latter when they looked
jagged. Growth pattern was classified in endophytic, exophytic, or
mixed considering lesion relations with the lumen of the digestive
canal. Necrosis was assessed when intratumoral low-attenuation
unenhanced areas were detected. Ulceration of the surface was272 www.jcat.org
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tract showed irregular and discontinuous focal defect. The degree
of contrast enhancement, which was measured as the change in at-
tenuation on portal venous phase images relative to unenhanced
images, was assessed.
For this purpose, 3 nonoverlapping regions of interest,
10-mm sized, were drawn manually within solid tumor parts on
unenhanced images and on venous phase images. The results were
averaged for both measurements. The difference of density (delta
of contrast enhancement, Δ) between the mean HU values on en-
hanced and unenhanced CT images was obtained for each lesion.
The statistic mean value of Δ was 55.33 HU; we considered as a
mild to low enhanced lesion when the Δ was less than 55.33 HU,
whereas high enhanced lesion was considered when a Δ greater
than or equal to 55.33 HU was observed.
Pattern of enhancement was assessed as homogenous or
heterogeneous. Invasion of adjacent organs was evaluated: an ill-
defined boundary of the lesion, not clearly dissociated from
surrounding structures, was considered as signs of invasion. Angio-
genesis was assessed when enlarged and engorged blood vessels
close to the lesion were detectable. Maximum intensity projection
reconstruction was used to obtain better assessment or to evaluate
the vascular anatomy. Peritoneal seeding was intended as a meta-
static mass located in the peritoneum or in the mesentery and not
close to the main tumor. The presence of intralesional calcifica-
tions and peritoneal effusion was also evaluated. A descriptive
analysis of all CT parameters evaluated was carried out. The rela-
tions between CT features and mitotic rate, classes of risk, lesion
size, and among all CT parameters were investigated.
Statistical Analysis
Numbers and percentage summarized categorical variables.
Relationships between CT features and mitotic rate, CT features
and classes of risk, CT features and lesion size, and among all
CT parameters were tested by χ2 test or Fisher exact test, when
needed. A P < 0.05 was considered statistically significant. A
professional statistician experienced with medical research per-
formed all the analyses using STATA 13.0 (StataCorp LP, College
Station, Tex).
RESULTS
Descriptive results of the CT features are reported in Table 1.
Pathological Findings
Among our cohort of 44 patients (pts), 11 pts (25%) had le-
sions with mitotic index greater than 5 (with a maximum record of© 2016 Wolters Kluwer Health, Inc. All rights reserved.
ealth, Inc. All rights reserved.
TABLE 1. Descriptive Results of the CT Features of GISTs
Pts Pts
n % n %
Margins Grow pattern
Regular 36 82% Exophytic 17 39%
Irregular 8 18% Mixed 13 30%
Necrosis Endophytic 14 31%
Present 25 57% C.E. pattern
Absent 19 43% Homogeneous 17 39%
Surface ulceration Heterogeneous 27 61%
Present 13 30% Location
Absent 31 70% Stomach 32 73%
Adjacent organ invasion Duodenum 4 9%
Present 4 9% Ileum 3 7%
Absent 40 91% Jejunum 2 5%
C.E. degree Esophagus 1 2%
Mild-low: ΔHU < 55.33 22 50% Mesentery 1 2%
High: ΔHU ≥ 55.33 22 50% Colon 1 2%
Calcifications Angiogenesis
Present 25 57% Present 14 32%
Absent 19 43% Absent 30 68%
Peritoneal effusion Size, cm
Present 5 11% ≤2 4 9%
Absent 39 89% >2 but ≤5 20 45%
Peritoneal seeding >5 but ≤10 9 21%
Present 3 7% >10 11 25%
Absent 41 93%
C.E. indicates contrast enhancement;ΔHU, the statistic median value of
the delta contrast enhancement.
TABLE 2. Relationships Between CT Features of GISTs and
Mitotic Rate
CT Features
Mitotic Rate
P
≤5/50 HPFs >5/50 HPFs
n % n %
33 11
Enhancement pattern
Heterogeneous 18 54.5 9 81.8 0.16
Homogeneous 15 45.5 2 18.2
Angiogenesis
Absent 25 75.8 5 45.5 0.132
Present 8 24.2 6 54.5
Calcifications
Absent 30 90.9 9 81.8 0.586
Present 3 9.1 2 18.2
Necrosis
Absent 17 51.5 2 18.2 0.081
Present 16 18.5 9 81.8
Surface ulceration
Absent 24 72.7 7 63.6 0.706
Present 9 27.3 4 36.4
Adjacent organ invasion
Absent 32 97.0 8 72.7 0.043
Present 1 3.0 3 27.3
Peritoneal effusion
Absent 31 93.9 8 72.7 0.051
Present 2 6.1 3 27.3
Peritoneal implants
Absent 32 97.0 9 81.8 0.15
Present 1 3.0 2 18.2
Margins
Regular 30 90.9 6 54.5 0.016
Irregular 3 9.1 5 45.5
Enhancement degree
Low-mild 14 42.4 8 72.7 0.116
High 19 57.6 3 27.3
In the column of the P values, the statistical significant correlations are
represented in bold.
J Comput Assist Tomogr • Volume 41, Number 2, March/April 2017 Pathology and CT feautures in GISTsmitoses of 180), whereas the other 33 pts (75%) had lesions with
mitotic index less than or equal to 5 (lowest recorded number
of mitoses, 0). Patients were divided, according to the reviewed
Miettinen classification, into 5 classes of risk: 3 pts (8%) as none
risk, 12 pts (27%) as very low risk, 9 pts (20%) as low risk, 9 pts
(20%) as moderate risk, and 7 pts (16%) as high risk. Four pts
(9%) of our sample who showed gastric, small bowel, or duodenal
lesions sized 2 cm or smaller and with a mitotic index greater than
5/50 HPFs were classified as insufficient data group as proposed
by Miettinen and were not included in the statistical analysis be-
tween CT features and classes of risk (Fig. 1).
A total correspondence was found between CT findings
and pathological data in the evaluation of the size of the lesions
and location.
Relations Between CT Features and Mitotic Rate
The parameter “margins”was statistically associatedwith the
mitotic index (P = 0.016) and with other organ invasion (P =
0.043). Other not statistically significant correlations are fully de-
tailed in Table 2.
Relations Between CT Features and Risk Class
Pattern of contrast enhancement (P = 0.002), angiogenesis
(P = 0.006), necrosis (P = 0.006), adjacent organ invasion (P =
0.011), and margins (P = 0.006) seemed to be statistically asso-
ciated with the classes of risk. Our results demonstrated that
the only CT parameter that showed a linear correlation with the© 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2017 Wolters Kluwer increase of risk was the parameter “margins.” Other not statisti-
cally significant correlations are fully reported in Table 3.
Relations Between CT Features and Lesion Size
Size of the lesion was associated with the pattern of con-
trast enhancement (P = 0.003), angiogenesis (P = 0.004), necrosis
(P = 0.003), adjacent organ invasion (P = 0.009), and margins
(P < 0.001). Other not statistically significant correlations are
fully described in Table 4.
Relations Among All the CT Features
Several correlations were found among the CT features: pat-
tern of contrast enhancement was associated with angiogenesis
(P = 0.023), necrosis (P < 0.001), and margins (P = 0.013). An-
giogenesis was associated with necrosis (P = 0.008), peritoneal
implants (P = 0.027), and margins (P = 0.016). Necrosis, be-
sides being associated with angiogenesis and pattern of contrastwww.jcat.org 273
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TABLE 3. Relationships Between CT Features of GISTs and Risk Classes
Risk Class
0 1 2 3 4
n n n n n
CT Features 3 % 12 % 9 % 9 % 7 % P
Enhancement pattern
Heterogeneous 1 33.3 3 25.0 5 55.6 8 88.9 7 100.0 0.002
Homogeneous 2 66.7 9 75.0 4 44.4 1 11.1 0 0.0
Angiogenesis
Absent 3 100.0 10 83.3 8 88.9 5 55.6 1 14.3 0.006
Present 0 0.0 2 16.7 1 11.1 4 44.4 6 85.7
Calcifications
Absent 3 100.0 10 83.3 9 100.0 7 77.8 6 85.7 0.706
Present 0 0.0 2 16.7 0 0.0 2 22.2 1 14.3
Necrosis
Absent 2 66.7 9 75.0 5 55.6 2 22.2 0 0.0 0.006
Present 1 33.3 3 25.0 4 44.4 7 77.8 7 100.0
Surface ulceration
Absent 3 100.0 8 66.7 4 44.4 8 88.9 4 57.1 0.211
Present 0 0.0 4 33.3 5 55.6 1 11.1 3 42.9
Adjacent organ invasion
Absent 3 100.0 12 100.0 6 100.0 9 100.0 4 57.1 0.011
Present 0 0.0 0 0.0 3 33.3 0 0.0 3 42.9
Peritoneal effusion
Absent 3 100.0 12 100.0 8 88.9 7 77.8 6 85.7 0.541
Present 0 0.0 0 0.0 1 11.1 2 22.2 1 14.3
Peritoneal implants
Absent 3 100.0 12 100.0 9 100.0 8 88.9 6 85.7 0.427
Present 0 0.0 0 0.0 0 0.0 1 11.1 1 14.3
Margins
Regular 3 100.0 12 100.0 9 100.0 7 77.8 3 42.9 0.006
Irregular 0 0.0 0 0.0 0 0.0 2 22.2 4 57.1
Enhancement degree
Low-mild 1 33.3 5 41.7 3 33.3 7 77.8 4 57.1 0.332
High 2 66.7 7 58.3 6 66.7 2 22.2 3 42.9
In the column of the P values, the statistical significant correlations are represented in bold. This analysis was performed on 40 patients, belonging
4 patients to the “insufficient data group.”
Risk classes: 0, none risk; 1, very low risk; 2, low risk; 3, moderate risk; 4, high risk.
Iannicelli et al J Comput Assist Tomogr • Volume 41, Number 2, March/April 2017enhancement, was found to be statistically associated with mar-
gins (P = 0.007).
The parameter “margins,” besides being associated with the
parameter pattern of contrast enhancement, angiogenesis, and ne-
crosis, was found to be statistically associated with invasion of ad-
jacent organs (P = 0.001) and with peritoneal implants (P =
0.004). The other not statistically significant correlations are fully
described in Table 5.DISUCSSION
Gastrointestinal stromal tumors usually affect the stomach
(60%–70%) and small bowel (20%–30%) and less frequently affect
the esophagus (5%), rectum, and colon (5%); rarely, they could
arise outside the GI (called e-GISTs).2–4 Their clinical presenta-
tion is extremely variable and depends on tumor location, biolog-
ical features, and disease spread. Gastrointestinal stromal tumors
might be asymptomatic, and diagnosis might be incidental during274 www.jcat.org
Copyright © 2017 Wolters Kluwer Hradiological, endoscopic, or surgical procedures.16–20 They usually
arise from the intestinal wall, notably from the outer muscular layer,
so they can have exophytic, endophytic, or mixed growth pattern
with a size varying from several millimeters to greater than 30 cm.
These tumors usually present areas of necrosis, cystic degen-
eration, or hemorrhage, phenomena often seen in larger lesions.6,7,10
Gastrointestinal stromal tumors have a large spectrum of behav-
iors, with a biologic potential at all sites of their occurrence.
Miettinen and Lasota4 developed the currently used risk stratifica-
tion. This classification combines tumor size, mitotic count, and tu-
mor location and stratifies GIST prognosis into 5 classes (Fig. 1).
Few previous studies had investigated the correlation of GIST
CT findings with pathology; however, to our knowledge, no sim-
ilar studies focused on associations among CT features, mitotic
rate, classes of risk, and tumor size had been carried out.10,12–15
Indeed, the latest article published on a similar topic by
Pinaikul et al12 was mainly focused on the correlation between
the CT features and the histological findings.© 2016 Wolters Kluwer Health, Inc. All rights reserved.
ealth, Inc. All rights reserved.
TABLE 4. Relationships Between Size of GISTs and CT Features
Size
≤2 cm >2 cm but ≤5 cm >5 cm but ≤10 cm >10 cm
n n n n
CT Features 4 % 20 % 9 % 11 % P
Enhancement pattern
Heterogeneous 1 25.0 8 40.0 7 77.8 11 100.0 0.003
Homogeneous 3 75.0 12 60.0 2 22.2 0 0.0
Angiogenesis
Absent 4 100.0 17 85.0 6 66.7 3 27.3 0.004
Present 0 0.0 3 15.0 3 33.3 8 72.7
Calcifications
Absent 4 100.0 17 85.0 9 100.0 9 81.8 0.671
Present 0 0.0 3 15.0 0 0.0 2 18.2
Necrosis
Absent 3 75.0 13 65.0 3 33.3 0 0.0 0.003
Present 1 25.0 7 35.0 6 66.7 11 100.0
Surface ulceration
Absent 4 100.0 13 65.0 5 55.6 9 81.8 0.354
Present 0 0.0 7 35.0 4 44.4 2 18.2
Adjacent organ invasion
Absent 4 100.0 20 100.0 9 100.0 7 63.6 0.009
Present 0 0.0 0 0.0 0 0.0 4 36.4
Peritoneal effusion
Absent 4 100.0 18 90.0 9 100.0 8 72.7 0.262
Present 0 0.0 2 10.0 0 0.0 3 27.3
Peritoneal implants
Absent 4 100.0 20 100.0 9 100.0 8 72.7 0.048
Present 0 0.0 0 0.0 0 0.0 3 27.3
Margins
Regular 4 100.0 20 100.0 9 100.0 3 27.3 <0.001
Irregular 0 0.0 0 0.0 0 0.0 8 72.7
Enhancement degree
Low-mild 1 25.0 9 45.0 5 55.6 7 63.6 0.546
High 3 75.0 11 55.0 4 44.4 4 36.4
In the column of the P values, the statistical significant correlations are represented in bold.
TABLE 5. P values of the Associations Among All the Investigated CT Features
Angiogenesis Calcifications Necrosis
Surface
Ulceration
Adjacent
Organ
Invasion
Peritoneal
Effusion
Peritoneal
Implants Margins
Enhancement
Degree
Pattern of enhancement 0.023 1.000 <0.001 0.988 0.147 0.139 0.155 0.013 1.000
Angiogenesis — 0.647 0.008 0.923 0.581 0.677 0.027 0.016 1.000
Calcifications 0.647 — 1.000 1.000 1.000 1.000 0.310 0.220 0.050
Necrosis 0.008 1.000 — 0.797 0.122 0.060 0.247 0.007 1.000
Surface ulceration 0.923 1.000 0.797 — 0.57 1.000 1.000 1.000 1.000
Adjacent organ invasion 0.581 1.000 0.122 0.570 — 0.394 0.254 0.001 1.000
Peritoneal effusion 0.677 1.000 0.060 1.000 0.394 — 0.310 0.219 1.000
Peritoneal implants 0.027 0.310 0.247 1.000 0.254 0.310 — 0.004 0.233
Margins 0.016 0.220 0.007 1.000 0.001 0.219 0.004 — 0.240
The table shows the P values, with the statistical significant ones in bold, obtained with the χ2 test by comparing the CT parameters with each other.
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Iannicelli et al J Comput Assist Tomogr • Volume 41, Number 2, March/April 2017Therefore, our work could be considered the first article
where many features related to GIST prognosis and behavior are
compared with CT findings to assess whether any CT findings
could be predictive or specific of the Miettinen classes of risk.
Therefore, we tried to give a useful contribution to our radiological
daily practice. Results displayed in Table 2 show a statistically sig-
nificant association between shape of lesion margins and mitotic
index: most (90.9%) of lesions with a number of mitosis less than
or equal to 5/50 HPFs showed regular margins (P = 0.016), sug-
gesting that solid lesionswith smooth and not crispy borders could
be less aggressive than the ones with jagged borders (Fig. 2).
All the tumorswith irregular margins (8 pts) were sized greater
than 10 cm, and 5 of them showed high mitotic index (Fig. 3). To
better analyze the relation between mitotic rate and margins, we
calculated the mean number of mitoses in the group with a mitotic
index greater than 5, taking into account lesions with both regular
and irregular margins. We found out that the mean number of mi-
toses was higher (ie, 58.5) among the lesions with irregular mar-
gins compared with the mean value of mitoses (ie, 32.8) detected
in neoplasms showing regular margins. This suggests that the mi-
totic index could be considered as a continuous variable as sug-
gested by the monogram proposed by Rossi et al.20
Therefore, the relation between the mitotic index and the
shape of the margins is influenced not only by the size of the lesion,
as generally believed and confirmed by the analysis we had per-
formed on lesions size and CT features (margins are associated
with lesion size with a P < 0.001), but also by the mitotic index.
The evidence that a pathological finding, such as the mitotic
index, could also influence a CT detectable feature such the shapeFIGURE 2. Gastric lesions both sized more than 10 cm with a low mitot
patient with a gastric exophytic lesion, 17-cm sized, 2 mitoses/50 HPFs b
shows a lesion with regular margins, heterogeneous pattern of contrast
(hematoxylin/eosin,400) shows the low cellularity and very lowmitotic
a 84-year-old ladywith gastric exophytic lesion, 13-cm sized, 4mitoses/5
axial (C) and coronal (D) planes. Figure 2 can be viewed online in color
276 www.jcat.org
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further research.
This association was not proofed elsewhere neither in a pre-
vious recent study where the associations among the pathological
findings and CT features were necrosis and peritoneal seeding.12
Thus, our result seems to be more interesting and quite new.
The mitotic index was also related (P < 0.043) with other or-
gan invasion, but we do not consider this result original or impres-
sive being the sample of lesions, which invaded other organs, was
small (only 4 lesions) and quite obvious that the mitotic index
could influence the tumor tendency to invade other organs.
It is worthwhile to point out that high contrast enhancement
and intratumoral heterogeneity, which usually are CT findings
suggestive of malignant lesions and reflect high cell density, hem-
orrhage, necrosis, and myxoid changes, in our study were not sig-
nificantly related with the mitotic index. These results suggest
that, in GISTs, these CT findings could be considered as inde-
pendent features from the mitotic count although they resulted
to be associated with the classes of risk and with the size of the le-
sions, which influence the biological behavior of GISTs as stated
by Miettinen.
Several CT findings seemed to be significantly related with
the risk of the aggressive clinical behavior of GISTs, such as pat-
tern of contrast enhancement (P = 0.002), angiogenesis (P = 0.006),
necrosis (P = 0.006), adjacent organ invasion (P = 0.011), and
margins (P = 0.006) (Table 3, Fig. 3).
An interesting finding was that the presence of irregular
margins showed a linear correlation with the risk classes, as it
was absent in the none, very low, and low classes (Fig. 4), whereasic rate (≤5/HPFs) of 2 different patients. A and B, A 39-year-old male
elonging to themoderate class of risk. A, Axial portal venous phase
enhancement, and wide necrosis inside. B, Photomicrograph
rate. C and D, Similar CT features are depicted in another patient,
0HPFs belonging to themoderate class of risk. Portal venous phase in
at www.jcat.org.
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FIGURE 3. Gastric lesions both sized more than 10 cmwith high mitotic rate (>5/HPFs) of 2 different patients. A and B, A 68-year-old female
patient with gastric exophytic lesion, 21-cm sized, 40mitoses/50HPFs, of the high risk class. A, Axial portal venous phase shows a lesionwith
irregular margins, heterogeneous pattern of contrast enhancement, and wide necrosis inside. B, MIP in axial arterial phase acquired in a lower
level shows noticeable angiogenesis (arrow). C andD, A 70-year-old female patient with gastric lesion, 12-cm sized, 147mitoses/50HPFs, of
the high class of risk. C, Axial portal venous phase shows a lesion with a mixed growth pattern, irregular margins, invasion of spleen, and
heterogeneous pattern of contrast enhancement with necrotic areas inside (arrows). D, Photomicrograph (hematoxylin/eosin, 400)
shows hypercellularity and very high mitotic rate (small single arrows). Figure 3 can be viewed online in color at www.jcat.org.
J Comput Assist Tomogr • Volume 41, Number 2, March/April 2017 Pathology and CT feautures in GISTsit could be observed in the 22.2% of the third class and in 57.1%
of the fourth class.
This result strengthens the evidence that, with the increase of
the risk, it increases the likelihood to detect irregular margins of
the lesion on CT images.
The presence of heterogeneous pattern of contrast enhance-
ment, angiogenesis, and necrosis was mainly observed in GISTs
belonging to the moderate and high classes of risk, and they
were respectively detected in 100%, 85.7%, and 100% of the
highest class. On the other hand, tumors belonging to the none
and very low risk classes appeared in most cases as lesions withFIGURE 4. GISTs with a lowmitotic rate (≤5/HPFs) of 2 different patients
patient with exophytic ileal lesion, 4-cm sized, 2 mitoses/50 HPFs. A, Ax
homogenous pattern of contrast enhancement. B, MIP in coronal arteria
artery. C, A 66-year-old female patient with gastric endophytic lesion, 7-
lesion with regular margins, quite homogenous pattern of contrast enha
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2017 Wolters Kluwer a homogenous pattern of contrast enhancement, without intra-
tumoral necrotic areas or angiogenesis, and with regular margins.
So, our study demonstrated that some imaging features could be
considered as expression of a worst prognosis in GISTs.
Furthermore, this relation is supported by the significant
associations of several CT features with the size of the tu-
mor, which is 1 of the 3 main prognostic factors in Miettinen
classification.
Tumor size seemed to be statistically significantly associated
with the pattern of contrast enhancement, angiogenesis, necrosis,
adjacent organ invasion, and margins (Table 4).both belonging to the low class of risk. A and B, A 54-year-old male
ial portal venous phase shows regular margins of the lesion and
l phase well depicts lesion's vascular supply by mesenteric superior
cm sized, 5 mitoses/50 HPFs. Axial portal venous phase shows a
ncement, and surface ulceration (arrow).
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the different classes of size showed that heterogeneous contrast
enhancement, irregular margins, and the other previously men-
tioned features trend to grow up with the increase of the size of
tumor, being mostly detected in tumors sized 5 to 10 and greater
than 10 cm (Fig. 3).
We only have to notice that the degree of contrast enhance-
ment, usually considered, if high, as a remarkable characteristic
of tumor biological activity, was not found to be associated with
neither mitotic rate nor the class of risk, in accordance with previ-
ous articles.10,12–15 In addition, by analyzing the relation among
all the CT features evaluated in this study (Table 5), a statistically
significant association (P < 0.005) between pattern of contrast
enhancement, necrosis, margins, and angiogenesis was found. It
is interesting to notice that, in our sample, all tumors with irregular
margins showed a heterogeneous enhancement and necrosis, and
in 75% of them, angiogenesis was present.
We would stress the concept that the presence of irregular
margins seems to be associated not only with the size of the le-
sion but also with the mitotic index, and it resulted to be the only
CT feature that showed a linear correlation with the increase of
the class of risk, making this relation of a strong and relevant
importance.
If the aim of researches is to find possible CT features that
really could reflect the clinical aggressiveness of GISTs, it is be-
hoove to point out howmuch important is to correlate CT findings
not only with the mitotic index, as done in previous studies, but
also with size of the lesions and with the Miettinen classes of risk
as proposed in our article.
Main limits of our study were as follows: (1) the study was
designed as retrospective, and (2) the sample of patients was not
equally distributed among the 2 mitotic index groups, thus re-
sulting in 2 not homogenous classes: 11 pts with a high number
of mitoses versus 33 pts with a lowmitotic index.We could justify
this limit considering that our article, to our knowledge, is the first
attempt to research any relations between the imaging features of
GISTs and its biological aggressiveness, expressed by mitotic rate
and the prognostic risk assessment. Computed tomography is a
fundamental tool in GISTevaluation and detection and contributes
to the risk stratification evaluating the size of the tumor and their
location; our article adds a value to the actual state of the art show-
ing that CT morphological features could be relate not only with
tumor size as yet known but also with pathological parameters,
the mitotic rate, and the expression of the tumor biology. Even
more interesting is the demonstration that several CT features
are related with the risk assessment, suggesting that CT parame-
ters could give a first step orientation, before the pathological ex-
amination, of the biological behavior of the lesion.
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